Hangzhou Converd Co., Ltd.

Organization

Hangzhou, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic agents comprising nucleic acids and TCR modified immune...
- Patent number 11,819,519
- Issue date Nov 21, 2023
- Hangzhou Converd Co., Ltd.
- Fang Hu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Isolated recombinant oncolytic adenoviruses, pharmaceutical composi...
- Patent number 11,806,374
- Issue date Nov 7, 2023
- HANGZHOU CONVERD CO., LTD.
- Jipo Sheng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic agents and uses thereof for drugs for treatment of tumo...
- Patent number 11,446,345
- Issue date Sep 20, 2022
- HANGZHOU CONVERD CO., LTD.
- Fang Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of oncolytic viruses as immunostimulants for treatment...
- Patent number 11,357,804
- Issue date Jun 14, 2022
- HANGZHOU CONVERD CO., LTD.
- Ronghua Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oral preparation and preparation method thereof
- Patent number 11,007,141
- Issue date May 18, 2021
- GUANGZHOU XIANGXUE PHARMACEUTICAL CO., LTD.
- Shuiping Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo individualized systemic immunotherapeutic method and device
- Patent number 10,980,859
- Issue date Apr 20, 2021
- Hangzhou Converd Co., Ltd.
- Fang Hu
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ISOLATED RECOMBINANT ONCOLYTIC ADENOVIRUSES, PHARMACEUTICAL COMPOSI...
- Publication number 20240100106
- Publication date Mar 28, 2024
- Hangzhou Converd Co., Ltd.
- Jipo SHENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENTS COMPRISING NUCLEIC ACIDS AND CAR-MODIFIED IMMUNE...
- Publication number 20230321238
- Publication date Oct 12, 2023
- HANGZHOU CONVERD CO., LTD.
- Fang HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING REGULATED...
- Publication number 20230265396
- Publication date Aug 24, 2023
- HANGZHOU CONVERD CO., LTD.
- Jin FU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...
- Publication number 20220339220
- Publication date Oct 27, 2022
- Hangzhou Converd Co., Ltd.
- Fang HU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PRODUCING VIRUS AND HARVEST LIQUID COMPOSITION
- Publication number 20220267713
- Publication date Aug 25, 2022
- HANGZHOU CONVERD CO., LTD.
- Yunfan LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC AGENTS COMPRISING NUCLEIC ACIDS AND TCR MODIFIED IMMUNE...
- Publication number 20210393686
- Publication date Dec 23, 2021
- HANGZHOU CONVERD CO., LTD.
- Fang HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition...
- Publication number 20200289591
- Publication date Sep 17, 2020
- Hangzhou Converd Co., Ltd.
- Jin Fu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isolated Recombinant Oncolytic Adenoviruses, Pharmaceutical Composi...
- Publication number 20200276252
- Publication date Sep 3, 2020
- Hangzhou Converd Co., Ltd.
- Jipo SHENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APPLICATION OF ONCOLYTIC VIRUSES AS IMMUNOSTIMULANTS FOR TREATMENT...
- Publication number 20200138882
- Publication date May 7, 2020
- Hangzhou Converd Co., Ltd.
- Ronghua ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Establishing Machine Learning Model for Predicting Toxic...
- Publication number 20200020420
- Publication date Jan 16, 2020
- Hangzhou Converd Co., Ltd.
- Jinlu Cai
Information Patent Application
THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...
- Publication number 20190343881
- Publication date Nov 14, 2019
- Hangzhou Converd Co., Ltd.
- Fang HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMO...
- Publication number 20190336549
- Publication date Nov 7, 2019
- Hangzhou Converd Co., Ltd.
- Fang HU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ORAL PREPARATION AND PREPARATION METHOD THEREOF
- Publication number 20190000756
- Publication date Jan 3, 2019
- GUANGZHOU XIANGXUE PHARMACEUTICAL CO., LTD.
- Shuiping SHI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG INCLUSION COMPOUND, PREPARATION THEREOF, AND PREPARATION METHO...
- Publication number 20190000859
- Publication date Jan 3, 2019
- GUANGZHOU XIANGXUE PHARMACEUTICAL CO., LTD.
- Shuiping SHI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In Vivo Individualized Systemic Immunotherapeutic Method and Device
- Publication number 20160250292
- Publication date Sep 1, 2016
- Hangzhou Converd Co., Ltd.
- Fang Hu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Hangzhou Converd Co., Ltd.

Organization

Patents Grantslast 30 patents

Therapeutic agents comprising nucleic acids and TCR modified immune...

Isolated recombinant oncolytic adenoviruses, pharmaceutical composi...

Therapeutic agents and uses thereof for drugs for treatment of tumo...

Application of oncolytic viruses as immunostimulants for treatment...

Oral preparation and preparation method thereof

In vivo individualized systemic immunotherapeutic method and device

Patents Applicationslast 30 patents

ISOLATED RECOMBINANT ONCOLYTIC ADENOVIRUSES, PHARMACEUTICAL COMPOSI...

THERAPEUTIC AGENTS COMPRISING NUCLEIC ACIDS AND CAR-MODIFIED IMMUNE...

ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING REGULATED...

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...

METHOD FOR PRODUCING VIRUS AND HARVEST LIQUID COMPOSITION

THERAPEUTIC AGENTS COMPRISING NUCLEIC ACIDS AND TCR MODIFIED IMMUNE...

Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition...

Isolated Recombinant Oncolytic Adenoviruses, Pharmaceutical Composi...

APPLICATION OF ONCOLYTIC VIRUSES AS IMMUNOSTIMULANTS FOR TREATMENT...

Method for Establishing Machine Learning Model for Predicting Toxic...

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CEL...

THERAPEUTIC AGENTS AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMO...

ORAL PREPARATION AND PREPARATION METHOD THEREOF

DRUG INCLUSION COMPOUND, PREPARATION THEREOF, AND PREPARATION METHO...

In Vivo Individualized Systemic Immunotherapeutic Method and Device